Newsroom

Sorted by: Latest

-

Mainstay Medical annonce les résultats sur deux ans de l'essai clinique RESTORE portant sur le ReActiv8®

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc a annoncé aujourd’hui la publication des résultats de l’évaluation à deux ans de l’essai clinique randomisé RESTORE portant sur le ReActiv8, destiné au traitement des lombalgies chroniques réfractaires. Les données montrent une amélioration continue de l'invalidité liée aux douleurs dorsales, de la douleur et de la qualité de vie dans le groupe traité par ReActiv8, ainsi que des améliorations après un an de traitement par ReActiv8 dans le g...
-

o9 Solutions Named a Leader in 2026 Nucleus Research Control Tower Technology Value Matrix

DALLAS--(BUSINESS WIRE)--o9 Solutions, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain platform, today announced that it has been named a Leader in the 2026 Nucleus Research Control Tower Technology Value Matrix. o9 was recognized for its Supply Chain Control Tower capabilities, which are integrated with the Company’s platform and Supply Chain Planning and analytics solutio...
-

VITURA : COMMUNIQUE DE MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2026

PARIS--(BUSINESS WIRE)--Regulatory News: Vitura (Paris:VTR): La société annonce avoir mis le 4 septembre 2026 à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son rapport financier semestriel au 30 juin 2026. Ce document est disponible sur le site Internet de Vitura (www.vitura.fr), rubrique Investisseurs / Rapport financier semestriel....
-

Vitura: Press Release on the Publication of the Half-yearly Financial Report as at 30 June 2026

PARIS--(BUSINESS WIRE)--Regulatory News: Vitura (Paris:VTR): The company announces that it has made available on 4 September 2026 to the public and filed with the Autorité des marchés financiers (AMF) its half-yearly financial report as at 30 June 2026. The document is available on Vitura’s website (www.vitura.fr), in the section Investors / Interim financial report....
-

Cloudflare se asocia con OpenAI Daybreak Models para redefinir la gestión de vulnerabilidades con una defensa perimetral basada en IA

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), la empresa líder en conectividad en la nube anunció el día de hoy el lanzamiento de "Vulnerability Discovery and Remediation", que está disponible en acceso anticipado a través de Cloudflare Managed Defense. A través de la red OpenAI Daybreak Defense Network, el servicio combina un análisis en profundidad del código y la generación automatizada de parches mediante los modelos de OpenAI Daybreak, entre ellos, GPT-5.6 Cyber, con datos...
-

Cloudflare kooperiert mit OpenAI-Daybreak-Modellen, um das Schwachstellenmanagement durch KI-gestützte Edge-Defense neu zu definieren

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), das führende Cloud-Unternehmen für Konnektivität, hat heute Vulnerability Discovery and Remediation eingeführt, das über Cloudflare Managed Defense frühzeitig verfügbar ist. Über das OpenAI Daybreak Defense Network verbindet der Service fundierte Code-Analysen und automatisierte Patch-Generierung mithilfe von OpenAI-Daybreak-Modellen – darunter GPT-5.6 Cyber – mit Echtzeit-Traffic und Sicherheitskontext aus dem globalen Netzwerk von...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Mainstay Medical gibt Zwei-Jahres-Ergebnisse aus der klinischen RESTORE-Studie zu ReActiv8® bekannt

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc gab heute die Veröffentlichung der Zwei-Jahres-Ergebnisse der randomisierten klinischen RESTORE-Studie zu ReActiv8 für die Behandlung von therapierefraktären chronischen Kreuzschmerzen bekannt. Die Daten zeigen fortlaufende Verbesserungen bei der durch Rückenschmerzen bedingten Beeinträchtigung, den Schmerzen und der Lebensqualität in der ReActiv8-Behandlungsgruppe sowie Verbesserungen nach einem Jahr ReActiv8-Therapie in der Crossover-Grup...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust...